In addition to the usual Medicare and Medicaid anti-fraud laws, labs have a new liability risk to contend with: stepped-up federal and state enforcement of antitrust laws. The driving force behind … [Read more...]
ANTITRUST
Enforcement Trends: New Emphasis on MD Practices Puts Labs at Growing Risk of Antitrust Enforcement
September 30, 2019
COURT CASES
Industry Trends: Small Labs Relying on Antitrust Laws to Protect Their Market Position
May 15, 2018
Frustrated by the consolidation taking place within the medical lab testing market, small and mid-sized labs that have not been swallowed up are fighting back by filing antitrust lawsuits against the … [Read more...]
ANTITRUST
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
May 15, 2018
Breast Cancer Recurrence Test Billing Case Ends in $2 Million Settlement Case: BioTheranostics has agreed to shell out $2 million to settle claims of falsely billing Medicare for its molecular Breast … [Read more...]
COURT CASES
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
February 27, 2018
HDL, Part II: Time to Hold the Individual Officers Accountable Case: Three years after Health Diagnostics Laboratory, Inc. (HDL) and its marketing partner BlueWave Healthcare Consultants—both now … [Read more...]
ANTITRUST
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
February 13, 2018
Allergy Firm Sues Quest for Antitrust Violations Case: Texas-based United Allergy Services (UAS) is suing Quest Diagnostics for conspiring with Thermo Fisher Scientific's Phadia business and other … [Read more...]
